The routine or screening obstetrical ultrasound examination

Clinical Obstetrics and Gynecology

Volumn 39, Issue 4, 1996, Pages 814-830

  Seeds, John W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

BIOMETRY; BIPARIETAL DISTANCE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; CROWN RUMP LENGTH; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FETUS MALFORMATION; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HIGH RISK PATIENT; HUMAN; MEDICAL LIABILITY; MULTICENTER STUDY; MULTIPLE PREGNANCY; NEURAL TUBE DEFECT; PLACENTA LOCALIZATION; PRACTICE GUIDELINE; REVIEW; SCREENING;

ABNORMALITIES; COST-BENEFIT ANALYSIS; FEMALE; GESTATIONAL AGE; HUMANS; LIABILITY, LEGAL; PATIENT SELECTION; PREGNANCY; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 0029803866     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199612000-00010     Document Type: Review

References (28)

1. Diagnostic Ultrasound imaging in Pregnancy. Washington, D.C. The Department of Health and Human Services, February, 1984.
2. Chervenak FA, et al. Advances in the diagnosis of fetal defects. N Engl J Med. 1986;315:305-309.
3. Seeds JW, Chescheir NC, Wade RV. Practical Sonography in Obstetrics and Gynecology. Philadelphia: Lippincott-Raven Publishers, 1996.
4. Adams MJ, Windham GC, Greenberg JF, et al. Clinical interpretation of maternal serum alpha-fetoprotein concentrations. Am J Obstet Gynecol. 1984;148:241-252.
5. Hook EB. Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol. 1981;58:282-288.
6. Watson WJ, Chescheir NC, Katz VL, Seeds JW. The role of ultrasound in evaluation of patients with elevated maternal serum alpha-fetoprotein: a review. Obstet Gynecol. 1991;78:123-130.
7. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med. 1992;327:588-594.
8. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol. 1988;95:334-338.
9. Petrocik E, Wassman ER, Kelly J. Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels. Am J Obstet Gynecol. 1989;161:1168-1172.
10. Merkatz IR, Nitowski HM, Macri JN, Johnson WE. An association between low maternal serum alphafetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984;148:886-891.
11. Macri JN, Haddow JE, Weiss RR. Screening for neural tube defects in the United States: a summary of the Scarborough conference. Am J Obstet Gynecol. 1979;133:119-221.
12. Haddow JE, Palomaki GE, Knight GJ, et al. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med. 1994;330:1114-1118.
13. Ewigman BG, Crane JP, Frigoletto FD, et al. Effect of prenatal ultrasound screening on perinatal outcome. N Engl J Med. 1993;329:821-827.
14. Crane JP, LeFevre ML, Winborn RC, et al. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management and outcome of anomalous fetuses. Am J Obstet Gynecol. 1994;171:392-399.
15. Ultrasonography in Pregnancy. ACOG Technical Bulletin Number 187. Washington, D.C.: The American College of Obstetricians and Gynecologists, December, 1993.
16. Guidelines for the Performance of the Antepartum Obstetrical Examination. Rockville, MD: American Institute of Ultrasound in Medicine, 1991.
17. Professional Liability for Residents. Washington, D.C.: Council on Resident Education in Obstetrics and Gynecology, 1993.
18. Kravitz RL, Rolph JE, McGuigan K. Malpractice claims data as a quality improvement tool: I. Epidemiology of error in four specialties. JAMA. 1991;266:2087-2092.
19. Hadlock FP, Harris RB, Martinez-Poyer J. How accurate is second trimester fetal dating? J Ultrasound Med. 1991;10:557-561.
20. Campbell S, Pearce JMF. The prenatal diagnosis of fetal structural anomalies by ultrasound. Clin Obstel Gynaecol. 1985;10:475-506.
21. Hill LM, Breckle R, Gehrking RT. Prenatal detection of congenital malformations by ultrasonography. Am J Obstet Gynecol. 1985;151:44-51.
22. Sabbagha RE, Sheikh Z, Tamura RK, et al. Predictive value, sensitivity, and specificity of ultrasonic targeted imaging for fetal anomalies in gravid women at high risk for birth defects. Am J Obstet Gynecol. 1985;152:822-888.
23. Levi S, Hyjazi Y, Schaaps JP, et al. Sensitivity and specificity of routine antenatal screening for congenital anomalies by ultrasound: the Belgian multicentric study. Ultrasound Obstet Gynecol 1991;1:102-108.
24. Bromley B, Estroff JA, Sanders SP, et al. Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol. 1992;166:1473-1479.
25. Copel JA, Pilu G, Green J, et al. Fetal echocardiographic screening for congenital heart disease: the importance of the four chamber view. Am J Obstet Gynecol. 1987;157:648-654.
26. Vergani P, Mariani S, Ghidini A, et al. Screening for congenital heart disease with the four chamber view of the heart. Am J Obstet Gynecol. 1992;167:1000-1009.
27. Platt LD, Feuchtbaum L, Filly R, et al. The California maternal serum alphafetoprotein screening program: the role of ultrasonography in the detection of spina bifida. Am J Obstet Gynecol. 1992;166:1328-1330.
28. Drugan A, Zador IE, Syner FN, et al. A normal ultrasound does not obviate the need for amniocentesis in patients with elevated serum alpha-fetoprotein. Obstet Gynecol. 1988;72:627-631.